Tandem Diabetes Care, Inc. TNDM has signed a multi-year collaboration agreement with the University of Virginia Center for Diabetes Technology (UVA). The partnership will focus on advancing research ...

A new study published in the NEJM Evidence journal showed that automated insulin delivery reduced hypoglycemia in older ...

Bernstein analyst Lee Hambright raised the firm’s price target on Tandem Diabetes (TNDM) to $44 from $42 and keeps an Outperform rating on the ...

UVA Center for Diabetes has signed an agreement to advance research on fully automated insulin delivery systems.

Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.

The Irvine, California-based company makes an insulin pump called the iLet Bionic Pancreas, which was cleared by the Food and ...

Life without a pancreas involves treatments to replace organ function. Learn how different surgical techniques affect overall ...

The global smart insulin pens market, currently estimated at US$ 3,927.3 million in 2023, is projected to exhibit robust ...

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN, Denmark and PALO ALTO, Calif.

Glooko’s integration of Hedia’s diabetes tech aims to improve care for patients and enhance healthcare provider insights.